Report of 9 new cases of leprosy studied in Centro Dermatológico Pascua during 2001

Myrna Rodríguez; Sara G Castillo

2003, Number 1

<< Back Next >>

Rev Cent Dermatol Pascua 2003; 12 (1)

Report of 9 new cases of leprosy studied in Centro Dermatológico Pascua during 2001

Rodríguez M, Castillo SG

Full text

How to cite this article

Language: Spanish
References: 10
Page: 15-22
PDF size: 112.54 Kb.

ABSTRACT

Leprosy is a chronic infection disease caused by Mycobacterium leprae that mainly affects the skin and periferic nerves. We report 9 new cases of leprosy studied in Centro Dermatológico Pascua during 2001.

REFERENCES

PAC Dermatología. 1ª edición 2000. Infecciones dermatológicas.
World Health Organization. The Final Push Towards Elimination of leprosy. Strategic Plan 2000-2005.
Saúl A. Lecciones de dermatología. 13ª edición. México. Méndez Cervantes editores 1998: 85-137.
Rodríguez O. Lepra clasificación y terminología. Rev Centro Dermatol Pascua 1992; 1(1) 27-34.
Terencio AJ. Lecciones de leprología. Fontilles 1973.
Castro BE. Servicio de Lepra. Rev Centro Dermatol Pascua 1997; 6(3) 131-136.
Rodríguez O. Tratamiento actual de la lepra. Dermatología Rev Mexicana Segunda Época 1987; 31(1-4) 29-33.
Abulafia J. Leprosy: pathogenesis update. Int J Dermatol 1999: 38, 321-334.
Grosset J. Newer drugs in leprosy. Int J Leprosy 69(Suppl. 2) S14-S18.
Grosset J. Combination of rifapentine-moxifloxacin minocycline (PMM) for the treatment of leprosy. Lepr Rev 2000; 71(Suppl.) S81-S87.